Form 4: Pediatrix Medical Group Executive Reports Stock Transaction
SEC Form 4 Filing
Mary Ann E. Moore, EVP, GC, Chief Admin Off & Sec of Pediatrix Medical Group, reports a transaction involving common stock on March 1, 2025.
Summary
- On March 1, 2025, Mary Ann E. Moore, an executive at Pediatrix Medical Group, engaged in a transaction involving the company's common stock.
- 8,975 shares were withheld for payment of taxes upon vesting of shares at a price of $14.77.
- Following the transaction, Moore directly owns 126,835 shares of common stock.
- Moore also indirectly owns 15,730 shares through a trust.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax withholding related to vesting shares.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of stock transaction |
| 03/04/2025 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.